Literature DB >> 17079794

Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor.

Danijela Lucic1, Zhi Hua Huang, De Sheng Gu, Michael K Altenburg, Nobuyo Maeda, Theodore Mazzone.   

Abstract

Factors that regulate apolipoprotein E (apoE) secretion by macrophages will have important effects on vessel wall lipid flux and atherosclerosis. Macrophages express the LDL receptor, which binds apoE with high affinity and could thereby affect the net secretion of apoE from macrophages. In these studies, we demonstrate that treatment of J774 macrophages transfected to constitutively express a human apoE3 cDNA with simvastatin, to increase LDL receptor activity, reduces the secretion of apoE. To further examine the relationship between LDL receptor expression and apoE secretion from macrophages, mouse peritoneal macrophages (MPMs) were isolated from mice with constitutively high expression of human LDL receptor to increase overall LDL receptor expression by 2- to 3-fold. Cells with increased LDL receptor expression also showed reduced apoE secretion compared with MPMs with basal LDL receptor expression. The effect of changes in LDL receptor expression on apoE secretion was isoform-specific, with greater reduction of apoE4 compared with apoE3 secretion and no reduction of apoE2 secretion, paralleling the known affinity of each isoform for LDL receptor binding. The effect of the LDL receptor on apoE secretion for each isoform was further reflected in LDL receptor-dependent changes in apoE-mediated cholesterol efflux. These results establish a regulatory interaction between two branches of macrophage sterol homeostatic pathways that could facilitate a rapid response to changes in macrophage sterol content relative to need.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079794     DOI: 10.1194/jlr.M600259-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice.

Authors:  Delphine Eberlé; Roy Y Kim; Fu Sang Luk; Nabora Soledad Reyes de Mochel; Nathalie Gaudreault; Victor R Olivas; Nikit Kumar; Jessica M Posada; Andrew C Birkeland; Joseph H Rapp; Robert L Raffai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-22       Impact factor: 8.311

2.  Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner.

Authors:  Michael Altenburg; Lance Johnson; Jennifer Wilder; Nobuyo Maeda
Journal:  J Biol Chem       Date:  2007-01-18       Impact factor: 5.157

3.  Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation.

Authors:  Lance A Johnson; Hyung-Suk Kim; Melissa J Knudson; C Taylor Nipp; Xianwen Yi; Nobuyo Maeda
Journal:  J Lipid Res       Date:  2012-11-30       Impact factor: 5.922

4.  Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice.

Authors:  Michael Altenburg; Jose Arbones-Mainar; Lance Johnson; Jennifer Wilder; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-27       Impact factor: 8.311

5.  Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo.

Authors:  Zhi Hua Huang; Desheng Gu; Theodore Mazzone
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-17       Impact factor: 4.310

6.  Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors.

Authors:  Li Li; Patricia A Thompson; Richard L Kitchens
Journal:  J Lipid Res       Date:  2008-05-22       Impact factor: 5.922

7.  Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond.

Authors:  Avani A Pendse; Jose M Arbones-Mainar; Lance A Johnson; Michael K Altenburg; Nobuyo Maeda
Journal:  J Lipid Res       Date:  2008-12-05       Impact factor: 5.922

8.  Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice.

Authors:  J M Arbones-Mainar; L A Johnson; M K Altenburg; N Maeda
Journal:  Int J Obes (Lond)       Date:  2008-08-26       Impact factor: 5.095

9.  ApoE polymorphism may determine low-density lipoprotein cholesterol level in association with obesity and metabolic syndrome in postmenopausal Korean women.

Authors:  Duck-Joo Lee; Kwang-Min Kim; Bom-Taeck Kim; Kyu-Nam Kim; Nam-Seok Joo
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

Review 10.  Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors.

Authors:  Mitsuru Shinohara; Naoyuki Sato; Munehisa Shimamura; Hitomi Kurinami; Toshimitsu Hamasaki; Amarnath Chatterjee; Hiromi Rakugi; Ryuichi Morishita
Journal:  Front Aging Neurosci       Date:  2014-04-23       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.